130 filings
8-K
PCSA
Processa Pharmaceuticals Inc
11 Apr 24
Regulation FD Disclosure
8:00am
8-K
PCSA
Processa Pharmaceuticals Inc
4 Apr 24
Regulation FD Disclosure
12:05pm
8-K
PCSA
Processa Pharmaceuticals Inc
21 Feb 24
Regulation FD Disclosure
5:25pm
8-K
PCSA
Processa Pharmaceuticals Inc
6 Feb 24
Other Events
8:30am
8-K
PCSA
Processa Pharmaceuticals Inc
30 Jan 24
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
10:46am
8-K
9mbowz46
25 Jan 24
NGC-Cap was better tolerated with positive preliminary efficacy results than FDA-approved capecitabine
8:35am
8-K
8u02uqd6b qz7io
19 Jan 24
Processa Pharmaceuticals Announces Expansion of NGC-Cap Program into Advanced or Metastatic Breast Cancer
8:00am
8-K
zt5df
18 Jan 24
Material Modifications to Rights of Security Holders
8:30am
8-K
jlai5cshi
8 Jan 24
Regulation FD Disclosure
4:30pm
8-K
cis78uwnlc 8apmw
19 Dec 23
FDA acknowledges that NGC-Cap is a New Chemical Entity given the changes to metabolism and distribution of its major metabolite 5-FU
9:00am
8-K
lqzx ta4j0q5jqv
5 Dec 23
Regulation FD Disclosure
5:18pm
8-K
uhqcqd2xp86fht5
16 Nov 23
Regulation FD Disclosure
3:10pm
8-K
to16 lbkjnnkx74klc
15 Nov 23
Submission of Matters to a Vote of Security Holders
11:30am
8-K
zmu062slidozjvj0f
13 Nov 23
Departure of Directors or Certain Officers
2:45pm
8-K
qml21ymn9bo1ose
16 Oct 23
Regulation FD Disclosure
9:15am
8-K
4u4 3repylv1i
21 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:29pm
8-K
wt2a4f
17 Aug 23
Regulation FD Disclosure
12:00pm
8-K
fbs7rq5
8 Aug 23
Processa Pharmaceuticals Appoints Life Sciences Industry Veteran George Ng as Chief Executive Officer
10:30am
8-K
pjuqmfkk2x t4
29 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:18pm
8-K
bqxfbl
21 Jun 23
Regulation FD Disclosure
12:30pm